241 related articles for article (PubMed ID: 11584010)
1. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
Fujimoto M; Poe JC; Hasegawa M; Tedder TF
J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
[TBL] [Abstract][Full Text] [Related]
2. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.
Chan VW; Lowell CA; DeFranco AL
Curr Biol; 1998 May; 8(10):545-53. PubMed ID: 9601638
[TBL] [Abstract][Full Text] [Related]
3. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
[TBL] [Abstract][Full Text] [Related]
4. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
Bobbitt KR; Justement LB
J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
[TBL] [Abstract][Full Text] [Related]
5. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.
Sato S; Jansen PJ; Tedder TF
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13158-62. PubMed ID: 9371816
[TBL] [Abstract][Full Text] [Related]
6. CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification.
Fujimoto M; Poe JC; Hasegawa M; Tedder TF
Immunol Res; 2000; 22(2-3):281-98. PubMed ID: 11339363
[TBL] [Abstract][Full Text] [Related]
7. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity.
Ochi H; Watanabe T
Int Immunol; 2000 Oct; 12(10):1417-23. PubMed ID: 11007759
[TBL] [Abstract][Full Text] [Related]
9. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop.
Fujimoto M; Bradney AP; Poe JC; Steeber DA; Tedder TF
Immunity; 1999 Aug; 11(2):191-200. PubMed ID: 10485654
[TBL] [Abstract][Full Text] [Related]
10. CD72-mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3-kinase.
Venkataraman C; Lu PJ; Buhl AM; Chen CS; Cambier JC; Bondada S
Eur J Immunol; 1998 Oct; 28(10):3003-16. PubMed ID: 9808169
[TBL] [Abstract][Full Text] [Related]
11. CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity.
Tedder TF; Sato S; Poe JC; Fujimoto M
Keio J Med; 2000 Mar; 49(1):1-13. PubMed ID: 10750375
[TBL] [Abstract][Full Text] [Related]
12. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
Poe JC; Hasegawa M; Tedder TF
Int Rev Immunol; 2001; 20(6):739-62. PubMed ID: 11913948
[TBL] [Abstract][Full Text] [Related]
13. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals.
Nishizumi H; Horikawa K; Mlinaric-Rascan I; Yamamoto T
J Exp Med; 1998 Apr; 187(8):1343-8. PubMed ID: 9547345
[TBL] [Abstract][Full Text] [Related]
14. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
Poe JC; Fujimoto M; Jansen PJ; Miller AS; Tedder TF
J Biol Chem; 2000 Jun; 275(23):17420-7. PubMed ID: 10748054
[TBL] [Abstract][Full Text] [Related]
15. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
[TBL] [Abstract][Full Text] [Related]
16. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
[TBL] [Abstract][Full Text] [Related]
17. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
Cornall RJ; Cyster JG; Hibbs ML; Dunn AR; Otipoby KL; Clark EA; Goodnow CC
Immunity; 1998 Apr; 8(4):497-508. PubMed ID: 9586639
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the B cell by CD22: a requirement for Lyn.
Smith KG; Tarlinton DM; Doody GM; Hibbs ML; Fearon DT
J Exp Med; 1998 Mar; 187(5):807-11. PubMed ID: 9480991
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
20. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
